|Salary:||£36,028 to £40,125 per annum, inclusive of London Allowance (Grade 7)|
|Placed On:||14th May 2021|
|Closes:||25th June 2021|
An exciting project joint with the Francis Crick Institute to further develop a non-viral gene therapy for inherited retinal diseases. The successful applicant will carry out a wide range of duties including mouse subretinal injections of non-viral gene therapy vectors, molecular and immune biology techniques, transcriptomics, dose-response experiments, histology, imaging, genotyping, and immunocytochemistry.
The position is funded for a period of 12 months in the first instance.
Candidates with a PhD is essential, experience in the aforementioned techniques, and who are bright, independent and highly motivated, but willing and able to work effectively as part of a collaborative team are encouraged to apply. Additional skills may be required for testing in vivo models with functional tests, and necessary training will be provided where necessary.
Applicants should apply online. To access further details about the position and how to apply please click on the ‘Apply’ button above.
Informal enquiries about the post are encouraged and may be made to Prof Mariya Moosaje (email: firstname.lastname@example.org).
If you have any enquiries regarding the application process, please email: email@example.com.
Latest time for the submission of applications: 23.59.
Interview Date: TBC
UCL Taking Action for Equality
Our department holds an Athena SWAN Bronze award, in recognition of our commitment to advancing gender equality.
Type / Role: